Atticus Pharma
2 known investors
Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.
BiotechHealthtechMedical Devices
Investors · 2
Competitors · 4
by search overlap奥科达6 shared keywordsAucta develops therapeutics and drug delivery technologies based on proven molecular compounds. The company focuses on patient-centered treatments across multiple disease states.
ANI Pharmaceuticals6 shared keywordsANI Pharmaceuticals is a pharmaceutical company focused on rare disease treatments, developing and marketing therapies such as an intravitreal implant for chronic non-infectious uveitis. It is a publicly traded company serving patients through its rare disease and pharmaceutical product portfolio.
Actinium Pharmaceuticals, Inc.5 shared keywordsActinium Pharmaceuticals develops targeted radiotherapies using Actinium-225, including CD33-targeting Actimab-A for relapsed/refractory AML and ATNM-400, a pan-tumor radiotherapy for metastatic castration-resistant prostate cancer, NSCLC and breast cancer. The company also develops targeted conditioning agents for gene and cell therapy and holds Actinium-225 manufacturing technology.
AltaThera Pharmaceuticals4 shared keywordsAltaThera Pharmaceuticals develops hospital-use intravenous drug therapies for treating cardiovascular conditions such as atrial fibrillation, atrial flutter, and ventricular arrhythmias in adult and pediatric patients. Its intravenous approach to antiarrhythmic initiation aims to enable faster therapeutic assessment and more precise dosing for physicians in hospital settings.
Companies competing with Atticus Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Atticus Pharma do?
- Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.
- Who are Atticus Pharma's investors?
- Atticus Pharma's investors include AEON Foundry, VentureSouth.